Breast cancer research

Breast cancer,research,

exceptional, Opportunities,in Research,(2003–2006):

The grants,were awarded,for a period, of four years.

NCI, awarded, 10 grants for a total, estimate, of $11.6 million.

Clinical Trial,to Determine, Risk, of Breast-Cancer Recurrence.

(2005):

This clinical trial, is designed to select lymph node-negative,

hormone, receptor-positive, breast-cancers, for chemotherapy,

treatment,

Research Prevention

according to their risk, of recurrence, as measured by a test

called OncotypeDx.

Pre-Malignancy Program (2006):

A comprehensive, program,in breast-cancer pre-malignancy,

research,that includes the areas of prevention, etiology,

biology,

diagnosis, and molecular,epidemiology.

Early Detection Strategies

A total of $8.1 million dollars, will be awarded for the

following projects:

"Molecular Epidemiology, and Biology of Mammographic Density",

"Evaluate Different Decision-Making Approaches Used by Women

Recruited for Participation in Chemoprevention Trials",

"Early Detection-Evaluation Strategies,

to Improve, the Accuracy,of Mammography,

Interpretation,with the Breast-Cancer.

Many of the research projects, are, studying the changes in

breast cells,that result, in the development,of cancer from

normal breast cells,

Understanding

understanding, how and why,cancer cells, continue to grow and

divide.

Understanding, these changes, offers the opportunity,

to develop new drugs,to prevent, or treat, breast-cancer

spreading.

Treatment options

Breast-cancer research is aimed at finding new ways to detect,

diagnose, and treat the disease.

Women with breast-cancer now have many treatment options.

Many women want to learn all they can about the disease

and their treatment choices,

so that they can take an active part in decisions

about their medical care,

Studies show that the incidence of breast-cancer

is very low in some Asian countries

when compared to the other races.

Diet

One of the reasons is attributed to their diet.

Like in the case of Green Tea,

a compound called epigallocatechin-3 gall ate (EGCG) inhibits

the growth of breast cancer-cells

The foundation was started as a non-profit organization

dedicated to funding innovative clinical research.

In 2010, nearly $29 million was awarded to 173 scientists

across the globe.

BCRF directs at least 90 cents of every dollar raised directly

to research

Breast cancer research White rose

New! Comments